Acadia Pharmaceuticals Inc. announced that on July 18, 2023, the Compensation Committee of Acadia’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 19,903 shares of common stock and 11,988 restricted stock units to 16 new employees under Acadia’s 2023 Inducement Plan.
